Cirina Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Cirina General Information


Developer of blood-plasma testing products designed to detect cancer at the earliest stages. The company's blood-plasma testing products help to detect and monitor cancer at an early stage, enabling patients to take necessary and preventive actions in early stages of the disease.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 201 Gateway Boulevard
  • San Francisco, CA 94080
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cirina Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 31-May-2017 0000 Completed Startup
1. Early Stage VC (Series A) 01-Jan-2015 0000 0000 Completed Startup
To view Cirina’s complete valuation and funding history, request access »

Cirina Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Decheng Capital Venture Capital Minority 000 0000 000000 0
To view Cirina’s complete investors history, request access »